Efficacy and Safety of Pemigatinib in Participants With Solid Tumors With FGFR Mutations or Translocations (FIGHT-208)

Clinical trial NCT04003623 · TERMINATED

Trial details

NCT number: NCT04003623
Sponsor: Incyte Corporation
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced or Metastatic Solid Tumors FGFR Mutations FGFR Translocations

Start date: 2019-10-31
Primary completion: 2020-06-12
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.